Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans. [electronic resource]
Producer: 20070302Description: 36-46 p. digitalISSN:- 0946-1965
- Adolescent
- Adrenergic Uptake Inhibitors -- blood
- Adult
- Antidepressive Agents -- blood
- Aryl Hydrocarbon Hydroxylases -- metabolism
- Cytochrome P-450 CYP2C19
- Cytochrome P-450 CYP2D6 -- metabolism
- Cytochrome P-450 CYP3A
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System -- genetics
- Dextromethorphan -- metabolism
- Drug Interactions
- Enzyme Inhibitors -- pharmacokinetics
- Genotype
- Humans
- Male
- Mixed Function Oxygenases -- metabolism
- Morpholines -- blood
- Mutation
- Paroxetine -- blood
- Phenotype
- Reboxetine
- Reference Values
- Selective Serotonin Reuptake Inhibitors -- blood
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.